---
aliases: >-
  /news/mental-health-startup-cerebral-teams-with-alto-neuroscience-to-bring-precision-psychiatry-to-patients-homes
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    Mental health startup Cerebral teams with Alto Neuroscience to bring
    'precision psychiatry' to patients' homes
categories:
  - 'Medigy: Mental Health'
categorySlug:
  - 'medigy: mental health'
categoryUrl:
  - topic/medigy-mental-health
categoryLabel:
  - Mental Health
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-12-20'
description: >-
  Mental health startup Cerebral has inked a partnership with Alto Neuroscience
  to bring clinical trials for depression to patients’ homes.Through the
  collaboration, Cerebral is able to offer its networ
favIconImage: null
featuredImage:
  alt: >-
    Mental health startup Cerebral teams with Alto Neuroscience to bring
    'precision psychiatry' to patients' homes
  format: JPEG
  href: c0e2f379-f6e3-566a-83cd-b3cb990ba626-featuredImage.jpeg
  size:
    - 5874
    - 9780
  valid: true
  workPackage: 10412
  wpAttachment:
    fileName: Curated_Featured_Image.bO_3oVNgpHCvE0xAC6DHRT
    link: /api/v3/attachments/19998/content
featuredPdf: null
htmlMetaData:
  author: null
  description: >-
    Mental health startup Cerebral has inked a partnership with Alto
    Neuroscience to bring clinical trials for depression to patients’ homes.
    Through the collaboration, Cerebral is able to offer its network of members
    the opportunity to participate in at-home clinical research utilizing Alto’s
    biomarker platform and targeted drug candidates.
  generator: null
  viewport: 'width=device-width, initial-scale=1.0'
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: >-
    Mental health startup Cerebral has inked a partnership with Alto
    Neuroscience to bring clinical trials for depression to patients’ homes.
    Through the collaboration, Cerebral is able to offer its network of members
    the opportunity to participate in at-home clinical research utilizing Alto’s
    biomarker platform and targeted drug candidates.
  ogimage: >-
    https://qtxasset.com/fiercehealthcare/1639961614/Cerebral%20product%20in%20mobile%20app.png/Cerebral%20product%20in%20mobile%20app.png?VersionId=4.lqbCqjy.bO_3oVNgpHCvE0xAC6DHRT
  ogsite_name: FierceHealthcare
  ogtitle: >-
    Mental health startup Cerebral teams with Alto Neuroscience to bring
    'precision psychiatry' to patients' homes
  ogtype: null
  ogupdated_time: null
  ogurl: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: >-
    Cerebral, Food and Drug Administration (FDA),Pharmaceuticals, Research,
    Behavioral Health, home healthcare, Telehealth, Consumer-Driven
    Healthcare,Digital Health, Practices
id: 10412
identifier: News
lastMod: '2021-12-20T21:41:58.192034Z'
link:
  brand: fiercehealthcare.com
  href: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
  original: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
href: >-
  https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
original: >-
  https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
mastHead: NEWS
mdName: c0e2f379-f6e3-566a-83cd-b3cb990ba626.md
openGraphMetaData:
  ogdescription: >-
    Mental health startup Cerebral has inked a partnership with Alto
    Neuroscience to bring clinical trials for depression to patients’ homes.
    Through the collaboration, Cerebral is able to offer its network of members
    the opportunity to participate in at-home clinical research utilizing Alto’s
    biomarker platform and targeted drug candidates.
  ogtitle: >-
    Mental health startup Cerebral teams with Alto Neuroscience to bring
    'precision psychiatry' to patients' homes
  ogurl: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
  ogimage: >-
    https://qtxasset.com/fiercehealthcare/1639961614/Cerebral%20product%20in%20mobile%20app.png/Cerebral%20product%20in%20mobile%20app.png?VersionId=4.lqbCqjy.bO_3oVNgpHCvE0xAC6DHRT
  ogsite_name: FierceHealthcare
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
  medigyTopics:
    - 'Medigy: Mental Health'
  sourceUrl: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  fiercehealthcare-mental-health-startup-cerebral-teams-with-alto-neuroscience-to-bring-precision-psychiatry-to-patients-homes
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  Mental health startup Cerebral teams with Alto Neuroscience to bring
  'precision psychiatry' to patients' homes
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Sessions - Electronic Health Record
    permalink: /offering/sessions---electronic-health-record
    categories:
      - 'Symplur: EHR (Electronic Health Record)'
      - 'Medigy: Mental Health'
    offeringId: 18203
  - label: GrayMatters Prism
    permalink: /offering/graymatters-prism
    categories:
      - 'Symplur: Digital Therapeutics'
      - 'Medigy: Mental Health'
    offeringId: 17295
  - label: Aiberry's Solution
    permalink: /offering/aiberrys-solution
    categories:
      - 'Medigy: Mental Health'
    offeringId: 17133
  - label: Integrative Coordinated Care Platform (CCP)
    permalink: /offering/integrative-coordinated-care-platform-ccp
    categories:
      - 'Healthcare IT News: Electronic Health Records (EHR)'
      - 'Medigy: Mental Health'
    offeringId: 16462
  - label: Carenodes Platform
    permalink: /offering/carenodes-platform
    categories:
      - 'Medigy: Mental Health'
      - 'Healthcare IT News: Behavioral Health'
    offeringId: 13367
twitterMetaData:
  twittercard: summary_large_image
  twitterdescription: >-
    Mental health startup Cerebral has inked a partnership with Alto
    Neuroscience to bring clinical trials for depression to patients’ homes.
    Through the collaboration, Cerebral is able to offer its network of members
    the opportunity to participate in at-home clinical research utilizing Alto’s
    biomarker platform and targeted drug candidates.
  twittertitle: >-
    Mental health startup Cerebral teams with Alto Neuroscience to bring
    'precision psychiatry' to patients' homes
  twitterimage: >-
    https://qtxasset.com/fiercehealthcare/1639961614/Cerebral%20product%20in%20mobile%20app.png/Cerebral%20product%20in%20mobile%20app.png?VersionId=4.lqbCqjy.bO_3oVNgpHCvE0xAC6DHRT
  twitterurl: >-
    https://www.fiercehealthcare.com/tech/mental-health-startup-cerebral-teams-alto-neuroscience-to-bring-precision-psychiatry-to
---
<p>Mental health startup Cerebral has inked a partnership with Alto Neuroscience to bring clinical trials for depression to patients’ homes.</p><p>Through the collaboration, Cerebral is able to offer its network of members the opportunity to participate in at-home clinical research utilizing Alto’s biomarker platform and targeted drug candidates. The companies aim to conduct clinical trials of new drugs that can better match treatments with a person’s condition, an approach they called “precision psychiatry,”&nbsp;so patients feel better faster.</p><p>Cerebral and Alto plan to begin enrolling 200 patients in January.</p><p>It marks the first-ever clinical trial for depression that participants will participate in fully from home, eliminating barriers to access to mental health care that have plagued the U.S. healthcare system, especially during the pandemic.&nbsp;The trial will test the clinical-stage biopharmaceutical company's <a href="https://clinicaltrials.gov/ct2/show/NCT05118750"><strong>depression drug candidate, ALTO-300</strong></a>.</p><p>It comes at a time when more than 50 million people in the U.S. are living with a mental illness, including major depressive disorder and post-traumatic stress disorder (PTSD), and there is an urgent need to improve personalized care for these conditions.&nbsp;Stark evidence of this urgency is the continued rise of suicide rates in the U.S. over the last 20 years, especially among those aged 15-24, the companies said.</p>